Properties of midecamycin, a new macrolide antibiotic.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D001424:Bacterial Infections / Q000188:drug therapy*; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D004917:Erythromycin / Q000494:pharmacology; D007933:Leucomycins / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D051379:Mice; D008826:Microbial Sensitivity Tests; D011817:Rabbits; D051381:Rats; D014217:Troleandomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D007933:Leucomycins; D004917:Erythromycin; D014217:Troleandomycin